Skip to main content

March 2027

CFP closes 1 Feb

International Conferences on Cardio Metabolic Diseases

ICCMD 2027

International Conferences on Cardio Metabolic Diseases is a 2-day event in Hamilton, Canada on 5–6 March 2027, organized by TheIRES Conferences. Abstracts are due by 1 February 2027. Its call for papers covers Advanced Cardiac Imaging and Diagnostics, Heart Failure and Cardiomyopathy and Coronary Artery Disease and Interventional Cardiology, among other areas. TheIRES Conferences has 14 other upcoming conferences listed here.

Call for papers open

Important dates

  1. Abstract / full paper deadline

    In 79 days

  2. Conference

    Hamilton, Canada

All deadlines are as published by the organizer. Check the official website for the time zone.

About this conference

Dedicated to the exploration of cardio metabolic diseases, this international conference offers a platform for significant research discussions. Researchers can present their work through various formats, such as presentations, posters, and papers. Key areas of interest include the epidemiology, molecular mechanisms, and innovative therapeutic approaches that address the complexities of these diseases. Engaging keynote speakers and panel discussions will stimulate thought and innovation among participants. A commitment to interdisciplinary collaboration is at the heart of this conference, inviting contributions from diverse fields. Opportunities for networking will enhance interactions among professionals, potentially leading to future partnerships. Information regarding submission guidelines and conference registration will be provided on the event's website shortly. Join an in-depth examination of research and clinical practices concerning cardio metabolic diseases and their management.

Topics and scope

  • Advanced Cardiac Imaging and Diagnostics
  • Heart Failure and Cardiomyopathy
  • Coronary Artery Disease and Interventional Cardiology
  • Arrhythmias and Electrophysiology
  • Stroke and Cerebrovascular Disorders
  • Pediatric Cardiology and Metabolic Health
  • Geriatric Cardiology and Healthy Aging
  • Inflammation and Cardiometabolic Diseases
  • Genetics and Genomics in Cardiometabolic Medicine
  • Gut Microbiome and Metabolic Disorders
  • Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolism
  • Insulin Resistance and Glucose Regulation
  • Novel Drug Development for Cardiometabolic Diseases
  • Pharmacological Advances in Diabetes Care
  • Cardiometabolic Risk Assessment and Prediction Models
  • Population Health and Epidemiology
  • Community-Based Prevention Programs
  • Health Policy and Healthcare Systems
  • Telemedicine and Remote Patient Monitoring
  • Wearable Technologies for Cardiometabolic Health
  • Big Data Analytics in Cardiovascular Medicine
  • Machine Learning Applications in Disease Prediction
  • Artificial Intelligence in Clinical Decision Support
  • Rehabilitation and Secondary Prevention
  • Physical Activity and Exercise Interventions
  • Nutraceuticals and Functional Foods
  • Sleep Disorders and Cardiometabolic Health
  • Mental Health and Cardiometabolic Disease Burden
  • Women's Heart Health and Pregnancy-Related Metabolic Disorders
  • Global Challenges in Cardiometabolic Disease Management
  • Emerging Biomarkers and Precision Diagnostics
  • Regenerative Medicine and Stem Cell Therapy
  • Clinical Practice Guidelines and Evidence-Based Care
  • Healthcare Innovation and Digital Transformation
  • Sustainable Healthcare Approaches for Chronic Diseases
  • Mechanisms of insulin resistance and metabolic syndrome
  • Obesity and its impact on cardiovascular health
  • Role of nutrition and diet in managing cardiometabolic diseases
  • Exercise interventions and lifestyle modifications
  • Pharmacological advancements and therapeutic approaches
  • The impact of genetics and epigenetics on disease susceptibility
  • Psychosocial factors influencing disease progression and management
  • Health disparities and access to care in diverse populations
  • Innovations in technology for disease management and prevention

Call for papers

Abstracts are due by 1 February 2027. Submission details are on the official website.

Where this information comes from

Source
Submitted by the organizer
Listed on
2 November 2026
Verification
Reviewed by an editor before publishing
Reference
FCA2923686

Questions about ICCMD 2027

When and where is ICCMD 2027?

5–6 March 2027 in Hamilton, Canada.

Can I attend online?

This listing does not confirm an online option. Check the official website.

What is the submission deadline?

Abstracts are due by 1 February 2027.

How do I register?

Registration and fees are handled by the organizer on the official website.

Visit Website